USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
ACTINOBAC BIOMED, INC.
Address:
675 US HIGHWAY 1
NORTH BRUNSWICK, NJ 08902-
Phone:
N/A
URL:
N/A
EIN:
126398916
DUNS:
829616676
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
STTR Phase I $202,601.00 1

Award List:

Targeting B-cell lymphoma with Leukothera

Award Year / Program / Phase:
2012 / STTR / Phase I
Award Amount:
$202,601.00
Agency:
HHS
Principal Investigator:
Benjamin A. Belinka – 732-371-2694
Research Institution:
CANCER INSTITUTE OF NEW JERSEY
RI Contact:
Abstract:
DESCRIPTION (provided by applicant): B-cell lymphomas include Hodgkin's, and non-Hodgkin's lymphoma (NHL) (eg. mantle cell lymphoma (MCL), follicular lymphoma (FL), diffuse large B-cell lymphoma (DLBCL), and Burkitt lymphoma). More than 70,000 people willbe diagnosed with these B-cell… More